Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes

NCT03586284 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

51

Enrollment

OTHER

Sponsor class

Stopped Funding discontinued.

Conditions

Cytomegalovirus Anterior Uveitis

Interventions

DRUG: Valganciclovir Hydrochloride
DRUG: Ganciclovir Sodium
DRUG: Placebo Oral Tablet
DRUG: Topical placebo

Sponsor

University of California, San Francisco

Collaborators

[object Object]
[object Object]
[object Object]